Ontology highlight
ABSTRACT: Background
Myelodysplastic syndrome (MDS) is known to arise through the pathogenic bone marrow mesenchymal stem cells (MSC) by interacting with hematopoietic stem cells (HSC). However, due to the strong heterogeneity of MDS patients, it is difficult to find common targets in studies with limited sample sizes. This study aimed to describe sequential molecular changes and identify biomarkers in MSC of MDS transformation.Methods
Multidimensional data from three publicly available microarray and TCGA datasets were analyzed. MDS-MSC was further isolated and cultured in vitro to determine the potential diagnostic and prognostic value of the identified biomarkers.Results
We demonstrated that normal MSCs presented greater molecular homogeneity than MDS-MSC. Biological proce
SUBMITTER: Yin C
PROVIDER: S-EPMC10802074 | biostudies-literature | 2024 Jan
REPOSITORIES: biostudies-literature